title: Mesangial cells are responsible for orchestrating the renal podocytes injury in the context of malignant hypertension.
abstract: OBJECTIVE
  Two populations of renal cells fully possess functional contractile cell apparatus: mesangial cells and podocytes. Previous studies demonstrated that in the context of malignant hypertension overproduction of Angiotensin-II by the contracting mesangial cells aggravated hypercellularity and apoptosis of adjacent cell populations. The role of podocytes in pathogenesis of malignant hypertension is unclear. We investigated responsiveness of normal vs. hyperglycaemic podocytes to pressure in a model of malignant hypertension.
  
  
  METHODS
  Rat renal podocytes and mesangial cells were subjected to high hydrostatic pressure, using an in vitro model of malignant hypertension. Part of them was pre-exposed to hyperglycaemic medium. Alternatively, the cells were cultured in conditioned medium collected from mesangial cells pre-exposed to pressure.
  
  
  RESULTS
  Angiotensin-II was significantly increased in normoglycaemic mesangial cells subjected to pressure, triggering enhanced proliferation and apoptosis. No augmented Angiotensin-II, proliferation or apoptosis were evident in pressure-exposed normoglycaemic podocytes. In hyperglycaemic mesangial cells, but not podocytes, basal Angiotensin-II and apoptosis were augmented, along with abrogated proliferation. Challenge with exogenous Angiotensin-II or Angiotensin-II-containing conditioned medium, induced apoptosis both in podocytes and mesangial cells.
  
  
  CONCLUSIONS
  1. Unlike mesangial cells, podocytes do not respond to high pressure or hyperglycaemia per se. Resultantly, neither high pressure nor hyperglycaemia, trigger apoptosis of podocytes in vitro. However, surplus of Angiotensin-II, amply produced in vivo by the adjacent mesangial cells, would seem to be sufficient for initiating apoptosis of both mesangial cells and podocytes. 2. Hyperglycaemia abrogates cell replication. Resultantly, in diabetic patients regeneration of renal tissue damaged by the incidence of malignant hypertension may become compromised or completely lost.
authors: Research and Development Unit, Assaf Harofeh Medical Center, Zerifin, Israel.
authors: Sylvia
authors: S
authors: Berman
authors: Ramzia
authors: R
authors: Abu Hamad
authors: Shai
authors: S
authors: Efrati
mesh_terms: D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis; D049109:Cell Proliferation; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006874:Hydrostatic Pressure; D006943:Hyperglycemia / Q000150:complications / Q000378:metabolism; D006974:Hypertension, Malignant / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D050527:Mesangial Cells / Q000378:metabolism* / Q000473:pathology; D019899:Paracrine Communication; D050199:Podocytes / Q000378:metabolism* / Q000473:pathology; D051381:Rats
chemical_list: D017077:Culture Media, Conditioned; D000804:Angiotensin II; D005947:Glucose